by James Lyons-Weiler, PhD, Popular Rationalism, ©2026
(Feb. 6, 2026) — Scott Gottlieb’s Washington Post essay is rhetorically powerful and personally moving. It is also structurally incomplete—and that incompleteness matters, because it reproduces a double standard that has distorted U.S. vaccine policy, medical practice, and research priorities for decades.
The core claim of the piece is uncontroversial: viral infections can cause devastating long-term harm in a subset of people. Epstein-Barr virus, measles, HPV, enteroviruses—these associations are real, documented, and serious. No serious critic disputes that. But Gottlieb uses this reality to imply that opposition to current vaccine policy rests on a denial of viral harm. That implication is false, and it collapses under even modest scrutiny.
The actual dispute is not whether viruses can harm people. It is whether vaccines can also harm some people, whether those harms have been systematically minimized or obscured, and whether the medical system has allowed ideological commitment to vaccination to suppress safer, complementary, or alternative approaches to prevention and treatment.
On that question, Gottlieb’s essay is silent.
That silence is not neutral.
The Missing Symmetry: Vaccine Injury Also Exists
The same logic Gottlieb applies to viral infections applies—inescapably—to vaccines. Biological interventions administered at population scale will produce heterogeneous outcomes. Some people benefit greatly. Some are unaffected. Some are harmed.
Yet when long-term harms follow vaccination, the response is categorically different. Instead of investigation, we see denial. Instead of humility, certainty. Instead of expanded research, contraction.
Post-viral syndromes are described as tragic, complex, and deserving of massive research investment. Post-vaccine syndromes are dismissed as coincidence, anxiety, misinformation, or “anti-science.” That is not science. That is ideology.
If it is valid to argue that a small fraction of EBV infections lead to lymphoma decades later, it is equally valid to ask whether a small fraction of immune-modulating interventions—administered repeatedly, early in life, and without long-term inert placebos—may also produce delayed autoimmune, neurological, or inflammatory consequences in susceptible individuals.
The refusal to apply this symmetry is the central double standard.
Conflicts of Interest Are Not a Footnote
Gottlieb writes as a survivor of cancer. He also writes as a sitting board member of Pfizer and UnitedHealth Group. That fact is disclosed—but not grappled with.
When a former FDA Commissioner who now sits on pharmaceutical boards argues that political skepticism toward vaccines threatens public health, readers deserve more than disclosure. They deserve argumentative restraint and epistemic humility proportional to the conflicts involved.
Read the rest here.